Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subdermal Betadine to Reduce Microbacterial Bioburden During Posterior Spinal Fusion

NCT06744907 is registered in ClinicalTrials.gov with Akron Children's Hospital as lead sponsor.

NCT NCT06744907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06744907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subdermal Betadine to Reduce Microbacterial Bioburden During Posterior Spinal Fusion
Lead sponsor
Akron Children's Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 3, 2025
Completion date
November 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal fusion